Published in:
01-02-2004 | Poster presentation
Incidence and clinical relevance of heparin-induced antibodies in critically ill patients
Authors:
P Grigoriou, E Grouzi, P Evagelopoulou, A Haikali, I Spiliotopoulou, G Baltopoulos
Published in:
Critical Care
|
Special Issue 1/2004
Login to get access
Excerpt
Heparin-induced thrombocytopenia (HIT-II) is the most significant complication of heparin therapy depending on the type and the duration of therapy, and the patient population. Although its incidence is known to be high after cardiac and orthopaedic surgery [
1‐
3], it remains unknown in patients of a general intensive care unit (ICU patients). …